Assignee
BLUEBIRD BIO INC
US·29 granted patents·32 pending applications·351 citations·filing 2005–2025
Top patents by PatentIndex Score
61 records- 0197US11020466B2BCMA chimeric antigen receptorsBLUEBIRD BIO INC·Filed 2020·Granted Jun 1, 2021·17 cites·27 claims
- 0296US10383929B2BCMA chimeric antigen receptorsBLUEBIRD BIO INC·Filed 2015·Granted Aug 20, 2019·29 cites·21 claims
- 0395US10646558B2BCMA chimeric antigen receptorsBLUEBIRD BIO INC·Filed 2019·Granted May 12, 2020·19 cites·30 claims
- 0495US10639359B2BCMA chimeric antigen receptorsBLUEBIRD BIO INC·Filed 2019·Granted May 5, 2020·19 cites·21 claims
- 0595US10639358B2BCMA chimeric antigen receptorsBLUEBIRD BIO INC·Filed 2019·Granted May 5, 2020·19 cites·30 claims
- 0695US10624960B2BCMA chimeric antigen receptorsBLUEBIRD BIO INC·Filed 2019·Granted Apr 21, 2020·19 cites·15 claims
- 0795US10479975B2Methods of making T cell compositionsBLUEBIRD BIO INC·Filed 2015·Granted Nov 19, 2019·28 cites·21 claims
- 0895US7901671B2Therapeutic retroviral vectors for gene therapyBLUEBIRD BIO INC·Filed 2005·Granted Mar 8, 2011·41 cites·17 claims
- 0994US10927367B2CBLB endonuclease variants, compositions, and methods of useBLUEBIRD BIO INC·Filed 2019·Granted Feb 23, 2021·13 cites·12 claims
- 1094US10793843B2CBLB endonuclease variants, compositions, and methods of useBLUEBIRD BIO INC·Filed 2019·Granted Oct 6, 2020·13 cites·9 claims
- 1194US10457731B2Multipartite signaling proteins and uses thereofBLUEBIRD BIO INC·Filed 2018·Granted Oct 29, 2019·19 cites·27 claims
- 1293US10774343B2MND promoter chimeric antigen receptorsBLUEBIRD BIO INC·Filed 2015·Granted Sep 15, 2020·21 cites·11 claims
- 1393US10428142B2Multipartite signaling proteins and uses thereofBLUEBIRD BIO INC·Filed 2015·Granted Oct 1, 2019·19 cites·4 claims
- 1492US11834668B2Compounds for improved viral transductionBLUEBIRD BIO INC·Filed 2020·Granted Dec 5, 2023·3 cites·28 claims
- 1592US10907177B2Compounds for improved viral transductionBLUEBIRD BIO INC·Filed 2019·Granted Feb 2, 2021·9 cites·28 claims
- 1692US10196444B2Multipartite signaling proteins and uses thereofBLUEBIRD BIO INC·Filed 2014·Granted Feb 5, 2019·22 cites·27 claims
- 1790US10105451B2Therapeutic retroviral vectors for gene therapyBLUEBIRD BIO INC·Filed 2015·Granted Oct 23, 2018·4 cites·11 claims
- 1888US8034620B2Lentiviral packaging cells and uses thereforBLUEBIRD BIO INC·Filed 2007·Granted Oct 11, 2011·4 cites·14 claims
- 1987US9988644B2Compounds for improved viral transductionBLUEBIRD BIO INC·Filed 2012·Granted Jun 5, 2018·13 cites·56 claims
- 2085US10501759B2Compounds for improved viral transductionBLUEBIRD BIO INC·Filed 2018·Granted Dec 10, 2019·5 cites·29 claims
- 2184US9061031B2Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathyBLUEBIRD BIO INC·Filed 2014·Granted Jun 23, 2015·10 cites·21 claims
- 2281US10632212B2Therapeutic retroviral vectors for gene therapyBLUEBIRD BIO INC·Filed 2018·Granted Apr 28, 2020·1 cites·17 claims
- 2381US2024229070A1Compounds for improved viral transductionBLUEBIRD BIO INC·Filed 2023·Application pending·0 cites
- 2480US11261441B2Vectors and compositions for treating hemoglobinopathiesBLUEBIRD BIO INC·Filed 2018·Granted Mar 1, 2022·1 cites·13 claims
- 2576US12234296B2Sickled beta globin antibodiesBLUEBIRD BIO INC·Filed 2022·Granted Feb 25, 2025·0 cites·6 claims
- 2675US11535681B2Sickled beta globin antibodiesBLUEBIRD BIO INC·Filed 2018·Granted Dec 27, 2022·1 cites·5 claims
- 2775US11326183B2VCN enhancer compositions and methods of using the sameBLUEBIRD BIO INC·Filed 2017·Granted May 10, 2022·2 cites·19 claims
- 2871US11701435B2Therapeutic retroviral vectors for gene therapyBLUEBIRD BIO INC·Filed 2020·Granted Jul 18, 2023·0 cites·20 claims
- 2969US2026022337A1Sickle cell potency assayBLUEBIRD BIO INC·Filed 2025·Application pending·0 cites
- 3066US2026035480A1Sickled beta globin antibodiesBLUEBIRD BIO INC·Filed 2025·Application pending·0 cites
- 3165US2020071399A1Multipartite signaling proteins and uses thereofBLUEBIRD BIO INC·Filed 2019·Application pending·0 cites
- 3264US2021032658A1Mnd promoter chimeric antigen receptorsBLUEBIRD BIO INC·Filed 2020·Application pending·0 cites
- 3364US2026049979A1Beta-thalassemia potency assayBLUEBIRD BIO INC·Filed 2025·Application pending·0 cites
- 3461US2022259594A1Vectors and compositions for treating hemoglobinopathiesBLUEBIRD BIO INC·Filed 2022·Application pending·0 cites
- 3557US2026022403A1Vcn enhancer compositions and methods of using the sameBLUEBIRD BIO INC·Filed 2025·Application pending·0 cites
- 3657US2022002653A1Cell therapy vesselsBLUEBIRD BIO INC·Filed 2019·Application pending·0 cites
- 3753US2015329640A1Chimeric antigen receptors and immune cells targeting b cell malignanciesBLUEBIRD BIO INC·Filed 2013·Application pending·0 cites
- 3851US12234476B2VCN enhancer compositions and methods of using the sameBLUEBIRD BIO INC·Filed 2017·Granted Feb 25, 2025·0 cites·17 claims
- 3949US10280435B2Gene therapy methodsBLUEBIRD BIO INC·Filed 2017·Granted May 7, 2019·0 cites·16 claims
- 4048US2022154145A1Sickle cell potency assayBLUEBIRD BIO INC·Filed 2020·Application pending·0 cites
- 4148US2022163512A1Beta-thalassemia potency assayBLUEBIRD BIO INC·Filed 2020·Application pending·0 cites
- 4247US2015216903A1Compounds for improved viral transductionBLUEBIRD BIO INC·Filed 2013·Application pending·0 cites
- 4346US2021236546A1Nkg2d daric receptorsBLUEBIRD BIO INC·Filed 2018·Application pending·0 cites
- 4446US2024000847A1MethodsBLUEBIRD BIO INC·Filed 2021·Application pending·0 cites
- 4546US2021002621A1Ctla4 homing endonuclease variants, compositions, and methods of useBLUEBIRD BIO INC·Filed 2018·Application pending·0 cites
- 4646US2017226216A1Bcma chimeric antigen receptorsBLUEBIRD BIO INC·Filed 2015·Application pending·0 cites
- 4745US2024309361A1MethodsBLUEBIRD BIO INC·Filed 2022·Application pending·0 cites
- 4842US2019309274A1Il-10 receptor alpha homing endonuclease variants, compositions, and methods of useBLUEBIRD BIO INC·Filed 2017·Application pending·0 cites
- 4942US2022325336A1Transduction efficiency assayBLUEBIRD BIO INC·Filed 2020·Application pending·0 cites
- 5040US2019241910A1Genome edited immune effector cellsBLUEBIRD BIO INC·Filed 2017·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when BLUEBIRD BIO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →